Ranibizumab Intraocular and Sinequan (Doxepin Capsules)
Determining the interaction of Ranibizumab Intraocular and Sinequan (Doxepin Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: doxepin
Brand name: Sinequan, Sinequan, Silenor
Synonyms: Sinequan Capsules, Sinequan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Sinequan (Doxepin Oral Concentrate)
- Ranibizumab Intraocular-Sinex Long-Acting
- Ranibizumab Intraocular-Sinex Nasal Spray
- Ranibizumab Intraocular-Singulair
- Ranibizumab Intraocular-Singulair (Montelukast Chewable Tablets)
- Ranibizumab Intraocular-Singulair (Montelukast Oral Granules)
- Sinequan (Doxepin Capsules)-Ranibizumab ophthalmic
- Sinequan (Doxepin Capsules)-Ranitidine
- Sinequan (Doxepin Capsules)-Ranitidine Capsule
- Sinequan (Doxepin Capsules)-Ranitidine Hydrochloride
- Sinequan (Doxepin Capsules)-Ranitidine Injection
- Sinequan (Doxepin Capsules)-Ranitidine Suspension